• |
  • |
  • |
  • |
Donate

Project

A Phase II Multi-Center Randomized, Double-Blind Placebo-Controlled Study to Investigate the Efficacy and Safety of R05285119 in Children with ASD

Center:
Fiscal Year:
2019
Contact Information:
Project Description:
A Phase II Multi-Center Randomized, Double-Blind, 24-Week, 3-Arm, Parallel Group, Placebo-Controlled Study to Investigate the Efficacy and Safety of R05285119 in Children and Adolescents Age 5-17 with Autism Spectrum Disorder
Keyword(s):
Core Function(s):
Performing Research or Evaluation
Area of Emphasis
Health-Related Activities
Target Audience:
Professionals and Para-Professionals
Unserved or Under-served Populations:
None
Primary Target Audience Geographic Descriptor:
National
Funding Source:
COVID-19 Related Data:
N/A